Predictive oncology reports year end 2021 financial results and provides business update

Eagan, minn., march 31, 2022 (globe newswire) -- predictive oncology (nasdaq: poai), a knowledge-driven company focused on applying artificial intelligence (“ai”) to personalized medicine and drug discovery, today reported financial results for the year ended december 31, 2021, a period defined by growth, expansion and maturity, and provided an update on business activities.
POAI Ratings Summary
POAI Quant Ranking